1)Marumo K, Satomi Y, Miyaji N, et al:The prevalence of renal cell carcinoma:a nationwide surgery in Japan in 1997. Int J Urol 8:359-365, 2001
2)Pizzocaro G, Piva L, Colavita M, et al:Interferon adjuvant to radical nephrectomy in Robson stages Ⅱ and Ⅲ renal cell carcinoma:a multicentric randomized study. J Clin Oncol 19:425-431, 2001
3)Messing EM, Manola J, Wilding G, et al:Phase Ⅲ study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma:an Eastern Cooperative Oncology Group/Intergroup trial. J Clin Oncol. 21(7):1214-1222, 2003
4)Medical Research Council Renal Cancer Collaborators.:Interferon-alpha and survival in metastatic renal carcinoma:early results of a randomized controlled trial. Lancet;353:14-17, 1999
5)Pyrhonen S, Salminen E, Ruutu M, et al:Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. J Clin Oncol. 17:2859-2867, 1999
6)Negrier S, Escudier B, Lasset C, et al:Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie. N Engl J Med 338:1272-1278, 1998
7)Atzpodien J, Hoffmann R, Franzke M, et al:Thirteen-year, long-term efficacy of interferon 2alpha and interleukin 2-based home therapy in patients with advanced renal cell carcinoma. Cancer 95:1045-1050, 2002
8)Atzpodien J, Kirchner H, Jonas U, et al:Interleukin-2-and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma:a prospectively randomized trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group(DGCIN). J Clin Oncol 22:1188-1194, 2004
9)Mickisch GH, Garin A, van Poppel H, et al:Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma:a randomized trial. Lancet 358:966-970, 2001